Published in J Clin Oncol on February 20, 2007
Clinical practice patterns and cost effectiveness of human epidermal growth receptor 2 testing strategies in breast cancer patients. Cancer (2009) 2.63
Cost-Effectiveness of Pertuzumab in Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer. J Clin Oncol (2015) 1.88
Closing the evidence gap in the use of emerging testing technologies in clinical practice. JAMA (2008) 1.68
Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry. Breast Cancer Res Treat (2010) 1.59
Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients. Breast Cancer Res (2008) 1.40
Challenges to the translation of genomic information into clinical practice and health policy: Utilization, preferences and economic value. Curr Opin Mol Ther (2008) 1.08
Trastuzumab for small HER-2+ breast cancer: small tumor, big decision. Oncologist (2012) 1.08
Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers. Breast Cancer Res Treat (2010) 1.07
Media influence on Herceptin subsidization in Australia: application of the rule of rescue? J R Soc Med (2008) 1.03
Do the large benefits justify the large costs of adjuvant breast cancer trastuzumab? J Clin Oncol (2007) 1.03
Assessing the real-world cost-effectiveness of adjuvant trastuzumab in HER-2/neu positive breast cancer. Oncologist (2012) 0.91
Cost-effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers. Cancer (2012) 0.90
Looking back at 10 years of trastuzumab therapy: what is the role of HER2 testing? A systematic review of health economic analyses. Per Med (2009) 0.87
Economic evaluation of targeted cancer interventions: critical review and recommendations. Genet Med (2011) 0.85
HER2 evaluation and its impact on breast cancer treatment decisions. Public Health Genomics (2011) 0.83
The cost burden of trastuzumab and bevacizumab therapy for solid tumours in Canada. Curr Oncol (2008) 0.82
Utilization of HER2 genetic testing in a multi-institutional observational study. Am J Manag Care (2012) 0.82
Do economic evaluations of targeted therapy provide support for decision makers? Am J Manag Care (2011) 0.81
Do economic evaluations of targeted therapy provide support for decision makers? J Oncol Pract (2011) 0.78
Societal costs and benefits of treatment with trastuzumab in patients with early HER2neu-overexpressing breast cancer in Singapore. BMC Cancer (2011) 0.77
Role of NCCN in Integrating Cancer Clinical Practice Guidelines into the Healthcare Debate. Am Health Drug Benefits (2008) 0.76
Adjuvant Trastuzumab in HER2-Positive Early Breast Cancer by Age and Hormone Receptor Status: A Cost-Utility Analysis. PLoS Med (2016) 0.75
Multi-arm Cost-Effectiveness Analysis (CEA) comparing different durations of adjuvant trastuzumab in early breast cancer, from the English NHS payer perspective. PLoS One (2017) 0.75
Cost-effectiveness analysis of trastuzumab in the adjuvant treatment for early breast cancer. Glob J Health Sci (2014) 0.75
Saving costs in cancer patient management through molecular imaging. Eur J Nucl Med Mol Imaging (2017) 0.75
Population strategies to decrease sodium intake and the burden of cardiovascular disease: a cost-effectiveness analysis. Ann Intern Med (2010) 5.14
Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation. Ann Intern Med (2010) 4.16
Toward a 21st-century health care system: recommendations for health care reform. Ann Intern Med (2009) 3.85
Trends in inpatient treatment intensity among Medicare beneficiaries at the end of life. Health Serv Res (2004) 2.83
Cost-effectiveness of genotype-guided and dual antiplatelet therapies in acute coronary syndrome. Ann Intern Med (2014) 2.69
Geographic variation in health care spending in the United States: insights from an Institute of Medicine report. JAMA (2013) 2.68
Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging. JAMA (2006) 2.53
The prognostic value of diagnosing concurrent multiple myeloma in immunoglobulin light chain amyloidosis. Br J Haematol (2013) 2.45
Technology diffusion, hospital variation, and racial disparities among elderly Medicare beneficiaries: 1989-2000. Med Care (2005) 2.26
Association of Foxp3 regulatory gene expression with graft-versus-host disease. Blood (2004) 2.20
Correlation between NIH composite skin score, patient-reported skin score, and outcome: results from the Chronic GVHD Consortium. Blood (2012) 2.19
Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Ann Intern Med (2007) 2.16
Influence of race on inpatient treatment intensity at the end of life. J Gen Intern Med (2007) 2.07
Trends in implantable cardioverter-defibrillator racial disparity: the importance of geography. J Am Coll Cardiol (2005) 1.98
Adoptive immunotherapy with cytokine-induced killer cells for patients with relapsed hematologic malignancies after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant (2011) 1.96
Consequences of health trends and medical innovation for the future elderly. Health Aff (Millwood) (2005) 1.95
A menu without prices. Ann Intern Med (2008) 1.89
Systematic review: the effects of growth hormone on athletic performance. Ann Intern Med (2008) 1.78
Cost-effectiveness of defending against bioterrorism: a comparison of vaccination and antibiotic prophylaxis against anthrax. Ann Intern Med (2005) 1.69
Effectiveness and cost-effectiveness of vaccination against pandemic influenza (H1N1) 2009. Ann Intern Med (2009) 1.68
Transcatheter aortic valve replacement in nonsurgical candidates with severe, symptomatic aortic stenosis: a cost-effectiveness analysis. Circ Cardiovasc Qual Outcomes (2013) 1.68
Vein of Galen malformations in neonates: new management paradigms for improving outcomes. Neurosurgery (2012) 1.67
Essential elements of a technology and outcomes assessment initiative. JAMA (2007) 1.63
Cost-effectiveness of bypass surgery versus stenting in patients with multivessel coronary artery disease. Am J Med (2003) 1.63
Crypt loss is a marker of clinical severity of acute gastrointestinal graft-versus-host disease. Am J Hematol (2007) 1.53
Geographic variation in Medicare services. N Engl J Med (2013) 1.51
Three large-scale changes to the Medicare program could curb its costs but also reduce enrollment. Health Aff (Millwood) (2013) 1.50
Identification of mitogen-activated protein kinase signaling pathways that confer resistance to endoplasmic reticulum stress in Saccharomyces cerevisiae. Mol Cancer Res (2005) 1.48
Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels. Biol Blood Marrow Transplant (2012) 1.48
Racial disparity in cardiac procedures and mortality among long-term survivors of cardiac arrest. Circulation (2003) 1.45
Training synergies between medical informatics and health services research: successes and challenges. J Am Med Inform Assoc (2002) 1.42
Spontaneous systolic blood pressure elevation during temporary balloon occlusion increases the risk of ischemic events after carotid artery occlusion. Neurosurgery (2008) 1.41
Simple counts of ADL dependencies do not adequately reflect older adults' preferences toward states of functional impairment. J Clin Epidemiol (2008) 1.37
The effect of geriatrics evaluation and management on nursing home use and health care costs: results from a randomized trial. Med Care (2006) 1.37
Effectiveness and cost-effectiveness of expanded antiviral prophylaxis and adjuvanted vaccination strategies for an influenza A (H5N1) pandemic. Ann Intern Med (2009) 1.33
Overlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patient-reported outcomes: a Chronic Graft-versus-Host Disease Consortium study. Haematologica (2011) 1.32
Extracting subject demographic information from abstracts of randomized clinical trial reports. Stud Health Technol Inform (2007) 1.22
Cost-effectiveness analysis of nephron sparing options for the management of small renal masses. J Urol (2011) 1.21
Iatrogenic dissection during neurointerventional procedures: a retrospective analysis. J Neurointerv Surg (2011) 1.13
The U.S. physician workforce: serious questions raised, answers needed. Ann Intern Med (2004) 1.10
Hepatitic variant of graft-versus-host disease after donor lymphocyte infusion. Blood (2002) 1.10
Cost-effectiveness of recombinant human activated protein C and the influence of severity of illness in the treatment of patients with severe sepsis. J Crit Care (2003) 1.06
Health outcomes and costs of community mitigation strategies for an influenza pandemic in the United States. Clin Infect Dis (2010) 1.06
Assessment of joint and fascia manifestations in chronic graft-versus-host disease. Arthritis Rheumatol (2014) 1.04
Unsupervised method for extracting machine understandable medical knowledge from a large free text collection. AMIA Annu Symp Proc (2009) 1.04
Minimal residual disease monitoring with high-throughput sequencing of T cell receptors in cutaneous T cell lymphoma. Sci Transl Med (2013) 1.03
Cost-effectiveness of statins for primary cardiovascular prevention in chronic kidney disease. J Am Coll Cardiol (2013) 1.03
The cost-effectiveness of therapy with teriparatide and alendronate in women with severe osteoporosis. Arch Intern Med (2006) 1.02
Incidental extracardiac findings at coronary CT: clinical and economic impact. AJR Am J Roentgenol (2010) 1.01
A phase 1 study of imatinib for corticosteroid-dependent/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodies. Blood (2011) 1.01
Identification of hypoxia-regulated proteins in head and neck cancer by proteomic and tissue array profiling. Cancer Res (2004) 0.95
Impacts of informal caregiver availability on long-term care expenditures in OECD countries. Health Serv Res (2004) 0.95
Invariance and inconsistency in utility ratings. Med Decis Making (2005) 0.95
The costs of decedents in the Medicare program: implications for payments to Medicare + Choice plans. Health Serv Res (2004) 0.94
Cost effectiveness of alternative imaging strategies for the diagnosis of small-bowel Crohn's disease. Clin Gastroenterol Hepatol (2009) 0.94
Myxedema ascites in the posttransplant setting: case report. Am J Hematol (2002) 0.94
Lenalidomide, melphalan and dexamethasone in a population of patients with immunoglobulin light chain amyloidosis with high rates of advanced cardiac involvement. Haematologica (2013) 0.94
H-Y antigen-binding B cells develop in male recipients of female hematopoietic cells and associate with chronic graft vs. host disease. Proc Natl Acad Sci U S A (2013) 0.93
The potential impact of comparative effectiveness research on U.S. health care expenditures. Demography (2010) 0.93
Individualized cost-effectiveness analysis. PLoS Med (2011) 0.92
Perinatal screening for group B streptococci: cost-benefit analysis of rapid polymerase chain reaction. Pediatrics (2002) 0.91
Effects of rotational symmetry order on the solid state dynamics of phenylene and diamantane rotators. J Am Chem Soc (2005) 0.89
Knowing loved ones' end-of-life health care wishes: attachment security predicts caregivers' accuracy. Health Psychol (2011) 0.89
How CER could pay for itself--insights from vertebral fracture treatments. N Engl J Med (2011) 0.88
Heart transplantation and cardiac amyloidosis: approach to screening and novel management strategies. J Heart Lung Transplant (2011) 0.88
Magnetic resonance microimaging of a swine infarcted heart: Performing cardiac virtual histologies. Conf Proc IEEE Eng Med Biol Soc (2015) 0.88
Endovascular management of arteriovenous malformations and other intracranial arteriovenous shunts in neonates, infants, and children. Childs Nerv Syst (2010) 0.88
Safety and efficacy of defibrotide for the treatment of severe hepatic veno-occlusive disease. Ther Adv Hematol (2012) 0.84
Cost-effectiveness of early colectomy with ileal pouch-anal anastamosis versus standard medical therapy in severe ulcerative colitis. Ann Surg (2012) 0.83
Complete donor T-cell engraftment 30 days after allogeneic transplantation predicts molecular remission in high-risk chronic lymphocytic leukaemia. Br J Haematol (2010) 0.82
Early CMV viremia is associated with impaired viral control following nonmyeloablative hematopoietic cell transplantation with a total lymphoid irradiation and antithymocyte globulin preparative regimen. Biol Blood Marrow Transplant (2010) 0.81
Performance of the RAND appropriateness criteria. Med Decis Making (2003) 0.81
Rise of pay for performance: implications for care of people with chronic kidney disease. Clin J Am Soc Nephrol (2007) 0.80
Utilization and outcomes of the implantable cardioverter defibrillator, 1987 to 1995. Am Heart J (2002) 0.80
Laparoscopy in women with unexplained infertility: a cost-effectiveness analysis. Fertil Steril (2008) 0.79
Management of acute kidney injury in the intensive care unit: a cost-effectiveness analysis of daily vs alternate-day hemodialysis. Arch Intern Med (2008) 0.79
An economic analysis of conservative management versus active treatment for men with localized prostate cancer. J Natl Cancer Inst Monogr (2012) 0.79
Short tandem repeat and human leukocyte antigen mutations or losses confound engraftment and typing analysis in hematopoietic stem cell transplants. Hum Immunol (2011) 0.78
Successful surgical and medical treatment of rhizopus osteomyelitis following hematopoietic cell transplantation. Orthopedics (2012) 0.78
A cost-benefit analysis of preimplantation genetic diagnosis for carrier couples of cystic fibrosis. Fertil Steril (2009) 0.77
Trends in hospital treatment of ventricular arrhythmias among Medicare beneficiaries, 1985 to 1995. Am Heart J (2002) 0.77
Articles on diagnostic tests: a new series and an invitation to authors. Ann Intern Med (2002) 0.75
Health and economic benefits of early vaccination and nonpharmaceutical interventions for a human influenza A (H7N9) pandemic: a modeling study. Ann Intern Med (2014) 0.75
The confirmatory trial in comparative-effectiveness research. N Engl J Med (2009) 0.75
Costs and benefits of prenatal screening for cystic fibrosis. JAMA (1987) 0.75
More than a frog in the throat: a case series and review of localized laryngeal amyloidosis. Arch Otolaryngol Head Neck Surg (2012) 0.75
A predictable suite of helminth parasites in the long-billed dowitcher, Limnodromus scolopaceus, from the Chihuahua desert in Texas and Mexico. J Parasitol (2010) 0.75
Clinicopathologic Threshold of Acute Colorectal Graft-versus-Host Disease. Arch Pathol Lab Med (2016) 0.75